Translation – Initiation, Elongation, Termination, Proofreading, Post-Translational Modifications

Translation is the fundamental biological process by which the genetic information encoded in messenger RNA (mRNA) is used to synthesize proteins. This process occurs in the cytoplasm on ribosomes, which act as the molecular machinery for protein synthesis. The genetic code, a set of rules by which information encoded in genetic material (DNA or RNA sequences) is translated into proteins (amino acid sequences) by living cells, is read in triplets of nucleotides called codons. Each codon specifies a particular amino acid, with a few exceptions for stop signals.

The entire process of translation can be broadly divided into three main stages: initiation, elongation, and termination. Additionally, mechanisms like proofreading and post-translational modifications ensure the accuracy and functionality of the synthesized proteins.

Initiation of Translation

Initiation is the crucial first step where the ribosome assembles on the mRNA molecule and the first aminoacyl-tRNA (a tRNA molecule carrying an amino acid) binds to the start codon. This process requires several protein factors known as initiation factors (IFs).

Prokaryotic Initiation

In prokaryotes, translation initiation begins with the small ribosomal subunit (30S). This subunit binds to the mRNA molecule at a specific sequence called the Shine-Dalgarno sequence, which is located a few nucleotides upstream of the start codon (AUG). The Shine-Dalgarno sequence is complementary to a sequence at the 3' end of the 16S ribosomal RNA (rRNA), facilitating the precise positioning of the ribosome.

The initiation factors, IF1, IF2, and IF3, play critical roles. IF3 binds to the 30S subunit and prevents premature binding of the large ribosomal subunit (50S), ensuring that initiation occurs only with the mRNA. IF1 binds to the A-site of the 30S subunit, blocking it from premature tRNA binding.

The initiator tRNA, which carries N-formylmethionine (fMet) in bacteria, then binds to the start codon (AUG) in the P-site (peptidyl site) of the 30S subunit. This binding is facilitated by IF2, which also has GTP bound to it. The GTP bound to IF2 is hydrolyzed to GDP upon the successful binding of the initiator tRNA.

Finally, the 50S ribosomal subunit joins the complex, displacing IF1, IF2, and IF3. This forms the functional 70S initiation complex. IF3 is released, IF1 is released by the binding of the 50S subunit, and IF2-GDP is released after GTP hydrolysis. The initiator tRNA carrying fMet is now positioned in the P-site.

Eukaryotic Initiation

Eukaryotic initiation is more complex and involves a larger set of initiation factors (eIFs). The small ribosomal subunit (40S) does not bind to a Shine-Dalgarno sequence. Instead, it binds to the 5' cap structure of the eukaryotic mRNA.

The eIF4F complex, composed of eIF4E (binds the 5' cap), eIF4G (a scaffolding protein that interacts with eIF4E, the poly-A binding protein PABP, and the 40S subunit), and eIF4A (an RNA helicase that unwinds secondary structures in the mRNA), is essential for recruiting the 40S subunit to the mRNA.

The initiator tRNA in eukaryotes carries methionine (Met), not N-formylmethionine. This tRNA is charged by methionyl-tRNA synthetase and forms a complex with eIF2 and GTP. This ternary complex (eIF2-GTP-Met-tRNAi) is recruited to the 40S subunit.

The 40S subunit, bound to the initiator tRNA and eIF2-GTP, then scans along the mRNA from the 5' end in a 5' to 3' direction until it encounters the start codon (AUG). This scanning process is facilitated by the RNA helicase activity of eIF4A and the interaction of eIF4G with PABP, which circularizes the mRNA.

Once the start codon is recognized, a conformational change occurs, and initiation factors, including eIF2 and eIF3, are released. The large ribosomal subunit (60S) then binds to the 40S-mRNA-initiator-tRNA complex, forming the 80S initiation complex. This binding is promoted by elongation factor 1A (eEF1A) in its GTP-bound form. GTP hydrolysis by eEF1A and subsequent release of GDP and inorganic phosphate facilitate the joining of the subunits. The initiator tRNA is positioned in the P-site.

Elongation of Translation

Elongation is the stage where the polypeptide chain is synthesized by the sequential addition of amino acids. This cyclical process involves the binding of aminoacyl-tRNAs to the ribosome, the formation of peptide bonds, and the translocation of the ribosome along the mRNA. It requires elongation factors (EFs) and energy in the form of GTP.

The ribosome has three key sites for tRNA binding: the A-site (aminoacyl site), P-site (peptidyl site), and E-site (exit site).

Step 1: Aminoacyl-tRNA Binding

The first step is the binding of an incoming aminoacyl-tRNA to the A-site. This tRNA carries the amino acid specified by the next codon on the mRNA. In both prokaryotes and eukaryotes, this process is mediated by elongation factors.

In prokaryotes, EF-Tu (elongation factor Tu) bound to GTP binds to the specific aminoacyl-tRNA and delivers it to the A-site of the ribosome, provided the anticodon of the tRNA matches the codon on the mRNA. If the match is correct, EF-Tu hydrolyzes its bound GTP to GDP and is released. The correct binding is crucial for accuracy.

In eukaryotes, the analogous factor is eEF1A (eukaryotic elongation factor 1A), which also works with GTP. eEF1A-GTP binds the charged tRNA and delivers it to the A-site. GTP hydrolysis leads to the release of eEF1A-GDP.

Step 2: Peptide Bond Formation

Once the aminoacyl-tRNA is correctly positioned in the A-site, the next step is the formation of a peptide bond between the amino acid in the A-site and the growing polypeptide chain attached to the tRNA in the P-site. This reaction is catalyzed by the peptidyl transferase activity of the large ribosomal subunit, specifically by the rRNA component, making the ribosome a ribozyme.

The amino group of the amino acid in the A-site attacks the carboxyl group of the amino acid attached to the tRNA in the P-site, forming a new peptide bond. As a result, the polypeptide chain is transferred from the tRNA in the P-site to the tRNA in the A-site.

Step 3: Translocation

After the peptide bond is formed, the ribosome moves one codon further along the mRNA in the 5' to 3' direction. This movement, called translocation, shifts the tRNAs: the deacylated tRNA (without an amino acid) from the P-site moves to the E-site, and the tRNA carrying the growing polypeptide chain moves from the A-site to the P-site. The A-site is now empty and ready to accept a new aminoacyl-tRNA.

Translocation in prokaryotes is facilitated by EF-G (elongation factor G) which binds to the ribosome and, using the energy from GTP hydrolysis, causes the ribosome to move one codon along the mRNA.

In eukaryotes, the elongation factor eEF2 (eukaryotic elongation factor 2) performs a similar function, utilizing GTP hydrolysis to drive translocation.

The E-site, now occupied by the deacylated tRNA, releases the free tRNA molecule. This tRNA can then be recharged with its specific amino acid by aminoacyl-tRNA synthetase and re-enter the translation cycle. This three-step cycle of aminoacyl-tRNA binding, peptide bond formation, and translocation repeats for each codon, extending the polypeptide chain until a stop codon is reached.

Termination of Translation

Translation terminates when the ribosome encounters one of the three stop codons (UAA, UAG, UGA) in the mRNA. Unlike codons for amino acids, stop codons do not have corresponding tRNAs. Instead, they are recognized by proteins called release factors (RFs).

Prokaryotic Termination

In prokaryotes, there are two main release factors: RF1 and RF2.

• RF1 recognizes the UAA and UAG stop codons.
• RF2 recognizes the UAA and UGA stop codons.

When a stop codon enters the A-site, either RF1 or RF2 binds to it. This binding triggers the peptidyl transferase center of the ribosome to hydrolyze the bond between the polypeptide chain and the tRNA in the P-site, releasing the completed polypeptide.

A third release factor, RF3, is a GTPase that assists RF1 and RF2. It binds to the ribosome in a GTP-bound state and promotes the release of RF1 or RF2 from the ribosome after hydrolysis of the polypeptide.

Finally, ribosome recycling factors (RRF) and EF-G are involved in dissociating the ribosome subunits from the mRNA and releasing the remaining components, allowing them to participate in new rounds of translation.

Eukaryotic Termination

Eukaryotes have a single release factor, eRF1 (eukaryotic release factor 1), which recognizes all three stop codons (UAA, UAG, UGA). eRF1 has a structure similar to a tRNA and binds to the stop codon in the A-site.

Similar to prokaryotes, eRF1 triggers the hydrolysis of the ester bond linking the polypeptide to the tRNA in the P-site, releasing the protein.

A second factor, eRF3, a GTP-binding protein, assists eRF1. GTP hydrolysis by eRF3 promotes the dissociation of eRF1 from the ribosome.

Ribosome dissociation and recycling in eukaryotes involve other factors like ABCE1 (ATP-binding cassette, sub-family E, member 1), which helps separate the ribosomal subunits and release the mRNA.

Proofreading during Translation

While the genetic code is highly specific, errors can occur during translation, leading to the incorporation of incorrect amino acids. The cell has evolved mechanisms to minimize these errors and ensure protein fidelity. This "proofreading" occurs at several levels.

1. Aminoacyl-tRNA Synthetase Accuracy

The first layer of proofreading occurs during the charging of tRNA by aminoacyl-tRNA synthetases. Each synthetase enzyme is specific for a particular amino acid and its cognate tRNA(s). The enzyme has an editing or "exonucleolytic" site that can remove incorrectly attached amino acids. If an amino acid is mistakenly attached to a tRNA, the synthetase can often recognize and excise it.

2. Codon-Anticodon Recognition

The second level of proofreading happens at the ribosome during the binding of the aminoacyl-tRNA to the mRNA codon in the A-site. The ribosome itself contributes to this fidelity.

The correct base pairing between the mRNA codon and the tRNA anticodon is crucial. Mismatched base pairs are energetically less favorable and lead to a weaker interaction. The ribosome's structure and the conformation of the tRNA within the A-site are sensitive to correct pairing.

The elongation factors (EF-Tu/eEF1A) also play a role. After the aminoacyl-tRNA binds to the A-site, EF-Tu/eEF1A remains associated with the tRNA-codon complex for a brief period. If the codon-anticodon pairing is incorrect, the GTP hydrolysis by EF-Tu/eEF1A is slower, giving the incorrect tRNA more time to dissociate from the ribosome before the peptide bond is formed. Correct pairing leads to rapid GTP hydrolysis and stabilization of the aminoacyl-tRNA in the A-site.

The peptidyl transferase reaction itself is highly specific and generally proceeds only after correct codon-anticodon recognition has been established and stabilized.

Post-Translational Modifications (PTMs)

Once a polypeptide chain is synthesized, it is often not immediately functional. Many proteins undergo further modifications after translation, collectively known as post-translational modifications (PTMs). These modifications are crucial for protein folding, stability, localization, activity, and interaction with other molecules. PTMs can be reversible or irreversible.

1. Folding and Chaperones

Newly synthesized polypeptide chains often fold into specific three-dimensional structures, which are essential for their function. This folding process can occur spontaneously or with the help of molecular chaperones, such as heat shock proteins (HSPs). Chaperones assist in proper folding, prevent misfolding and aggregation, and can help refold denatured proteins.

2. Cleavage

Many proteins are synthesized as inactive precursors called proproteins or zymogens. These are activated by specific proteolytic cleavage events. For example, insulin is synthesized as preproinsulin, which is cleaved to proinsulin, and then further cleaved to mature insulin. Signal peptides, which direct proteins to specific cellular locations, are often cleaved off after they have served their purpose.

3. Covalent Modifications

A wide array of covalent modifications can be added to amino acid side chains or the N- and C-termini of proteins. Some common examples include:

• Phosphorylation: The addition of a phosphate group to serine, threonine, or tyrosine residues. This is a common regulatory mechanism, often involved in signal transduction pathways.
• Glycosylation: The attachment of carbohydrate chains (glycans) to asparagine (N-linked), serine, or threonine (O-linked) residues. Glycosylation is important for protein folding, stability, cell-cell recognition, and immune responses.
• Acetylation: The addition of an acetyl group, typically to the N-terminus of a protein or to lysine residues. Histone acetylation, for example, plays a key role in regulating gene expression.
• Methylation: The addition of a methyl group, often to lysine or arginine residues. It is involved in various cellular processes, including gene regulation and protein-protein interactions.
• Ubiquitination: The covalent attachment of ubiquitin, a small protein, to lysine residues. This can target proteins for degradation by the proteasome, or it can play roles in signaling and DNA repair.
• Lipidation: The attachment of lipid molecules, such as fatty acids or prenyl groups, to proteins. This can anchor proteins to cell membranes.
• Disulfide Bond Formation: The formation of covalent bonds between the sulfur atoms of two cysteine residues. This stabilizes the tertiary and quaternary structure of many extracellular proteins.

4. Addition of Prosthetic Groups

Some proteins require the addition of non-protein components, called prosthetic groups, to become functional. For example, heme groups are added to hemoglobin and cytochromes.

5. Amino Acid Modifications

Specific amino acids can be chemically modified. For instance, proline and lysine residues in collagen are hydroxylated to form hydroxyproline and hydroxylysine, which are essential for collagen's structural integrity.

In summary, translation is a highly regulated and intricate process involving initiation, elongation, and termination. The accuracy of protein synthesis is maintained through proofreading mechanisms at multiple stages. Furthermore, post-translational modifications diversify protein function and are critical for the ultimate biological activity and regulation of proteins within the cell.